TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.50
Delayed Data
As of May 22
 -0.04 / -0.61%
Today’s Change
3.44
Today|||52-Week Range
7.49
+46.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues3.8M4.2M4.3M4.5M
 
 
 
 
 
Cost of Goods Sold893.0K1.1M879.5K1.0M
 
 
 
 
 
Depreciation And Amortization14.1K12.7K12.6K13.6K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M3.1M3.4M3.4M
 
 
 
 
 
General Expenses13.8M21.0M19.7M24.3M
 
 
 
 
 
Research And Development8.2M14.9M14.2M18.2M
 
 
 
 
 
Total Operating Expenses14.7M22.0M20.6M25.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.9M-17.8M-16.3M-20.9M
 
 
 
 
 
Other Expenses18.6K6.3K3.2K18.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-17.8M-16.3M-20.9M
 
 
 
 
 
Net Income-10.9M-17.8M-16.3M-20.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS145.5M152.2M156.1M163.4M
 
 
 
 
 
Shares To Calculate EPS Diluted145.5M152.2M156.1M163.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.12-$0.10-$0.13
 
 
 
 
 
EPS Diluted-$0.07-$0.12-$0.10-$0.13
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account